Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15297440rdf:typepubmed:Citationlld:pubmed
pubmed-article:15297440lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C1704689lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0020615lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0017715lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0599781lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:15297440lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:15297440pubmed:issue11lld:pubmed
pubmed-article:15297440pubmed:dateCreated2004-10-18lld:pubmed
pubmed-article:15297440pubmed:abstractTextMice bearing IL-1beta-secreting tumor were used to study the chronic effect of IL-1beta on glucose metabolism. Mice were injected with syngeneic tumor cells transduced with the human IL-1beta gene. Serum IL-1beta levels increased exponentially with time. Secretion of IL-1beta from the developed tumors was associated with decreased food consumption, reduced body weight, and reduced blood glucose levels. Body composition analysis revealed that IL-1beta caused a significant loss in fat tissue without affecting lean body mass and water content. Hepatic phosphoenolpyruvate carboxykinase and glucose-6-phosphatase activities and mRNA levels of these enzymes were reduced, and 2-deoxy-glucose uptake by peripheral tissues was enhanced. mRNA levels of glucose transporters (Gluts) in the liver were determined by real-time PCR analysis. Glut-3 mRNA levels were up-regulated by IL-1beta. Glut-1 and Glut-4 mRNA levels in IL-1beta mice were similar to mRNA levels in pair-fed mice bearing nonsecreting tumor. mRNA level of Glut-2, the major Glut of the liver, was down-regulated by IL-1beta. We concluded that both decreased glucose production by the liver and enhanced glucose disposal lead to the development of hypoglycemia in mice bearing IL-1beta-secreting tumor. The observed changes in expression of hepatic Gluts that are not dependent on insulin may contribute to the increased glucose uptake.lld:pubmed
pubmed-article:15297440pubmed:languageenglld:pubmed
pubmed-article:15297440pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15297440pubmed:statusMEDLINElld:pubmed
pubmed-article:15297440pubmed:monthNovlld:pubmed
pubmed-article:15297440pubmed:issn0013-7227lld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:PappoOritOlld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:Chajek-ShaulT...lld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:BarashVardaVlld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:NusairSamirSlld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:ShilyanskyJoe...lld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:MetzgerShulam...lld:pubmed
pubmed-article:15297440pubmed:authorpubmed-author:PlanerDavidDlld:pubmed
pubmed-article:15297440pubmed:issnTypePrintlld:pubmed
pubmed-article:15297440pubmed:volume145lld:pubmed
pubmed-article:15297440pubmed:ownerNLMlld:pubmed
pubmed-article:15297440pubmed:authorsCompleteYlld:pubmed
pubmed-article:15297440pubmed:pagination5150-6lld:pubmed
pubmed-article:15297440pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:meshHeadingpubmed-meshheading:15297440...lld:pubmed
pubmed-article:15297440pubmed:year2004lld:pubmed
pubmed-article:15297440pubmed:articleTitleInhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor.lld:pubmed
pubmed-article:15297440pubmed:affiliationDepartment of Medicine, Hadassah University Hospital, Mount Scopus, P.O. Box 24035, Jerusalem 91240, Israel.lld:pubmed
pubmed-article:15297440pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3553entrezgene:pubmedpubmed-article:15297440lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15297440lld:entrezgene
lhgdn:association:8916lhgdn:found_inpubmed-article:15297440lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15297440lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15297440lld:pubmed